A randomized controlled trial assessing the prevention of doxorubicin cardiomyopathy by N-acetylcysteine.
D000111:Acetylcysteine / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D009202:Cardiomyopathies / Q000139:chemically induced* / Q000517:prevention & control; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D009369:Neoplasms / Q000188:drug therapy; D010349:Patient Compliance; D011897:Random Allocation; D013318:Stroke Volume / Q000187:drug effects
D004317:Doxorubicin; D000111:Acetylcysteine